Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Sanofi (SNY) shares slide following Q4 revenue miss
February 1, 2024 8:42 AM ESTSanofi (NASDAQ: SNY) shares are down premarket following its fourth-quarter earnings release, which saw revenue come in below consensus expectations.
The pharmaceutical and healthcare company reported Q4 EPS of EUR1.66, EUR0.74 better than the analyst estimate of EUR0.92. Revenue for the quarter was EUR10.92 billion versus the consensus estimate of EUR12.65 billion.
Q4 sales rose 9.3% year-on-year, with vaccine sales up... More
